Key result
In Pakistan, wild poliovirus type 1 cases declined by 43% from 147 cases in 2019 to 84 cases in 2020, with only one case reported as of August 2021.
Why the study?
Wild poliovirus type 1 transmission persisted in only two countries as of August 2021, necessitating an update on progress toward polio eradication in Pakistan.
Observational
WPV1 cases in Pakistan declined significantly in 2020 and 2021, though cVDPV2 outbreaks and surveillance disruptions due to COVID-19 remain challenges to polio eradication.
Answers are grounded in this paper and cite their sources.
Progress toward WPV1 eradication in Pakistan is encouraging; leaves open whether cVDPV2 and COVID-19 disruptions will reverse gains.
When the Global Polio Eradication Initiative began in 1988, wild poliovirus (WPV) transmission was occurring in 125 countries; currently, only WPV type 1 (WPV1) transmission continues, and as of August 2021, WPV1 transmission persists in only two countries (1,2). This report describes Pakistan's progress toward polio eradication during January 2020-July 2021 and updates previous reports (3,4). In 2020, Pakistan reported 84 WPV1 cases, a 43% reduction from 2019; as of August 25, 2021, Pakistan has reported one WPV1 case in 2021. Circulating vaccine-derived poliovirus (cVDPV) emerges as a result of attenuated oral poliovirus vaccine (OPV) virus regaining neurovirulence after prolonged circulation in underimmunized populations and can lead to paralysis. In 2019, 22 cases of cVDPV type 2 (cVDPV2) were reported in Pakistan, 135 cases were reported in 2020, and eight cases have been reported as of August 25, 2021. Because of the COVID-19 pandemic, planned supplementary immunization activities (SIAs)* were suspended during mid-March-June 2020 (3,5). Seven SIAs were implemented during July 2020-July 2021 without substantial decreases in SIA quality. Improving the quality of polio SIAs, vaccinating immigrants from Afghanistan, and implementing changes to enhance program accountability and performance would help the Pakistan polio program achieve its goal of interrupting WPV1 transmission by the end of 2022.
No takes yet. Share an insight, caveat, or question.
Mbaeyi et al. (2021) conducted an observational in Poliomyelitis (WPV1 and cVDPV2). Supplementary immunization activities (SIAs) with oral poliovirus vaccine vs. 2019 baseline (historical control) was evaluated on Reported wild poliovirus type 1 (WPV1) cases (43% reduction). In Pakistan, wild poliovirus type 1 cases declined by 43% from 147 cases in 2019 to 84 cases in 2020, with only one case reported as of August 2021.
Synapse has enriched 10 related papers. Consider them for comparative context: